Müller-Calleja N - Search Results

1

Induction of tissue factor expression by anti-β2-glycoprotein I is mediated by tumor necrosis factor α.

Hollerbach A, Müller-Calleja N, Canisius A, Orning C, Lackner KJ. Hollerbach A, et al. Among authors: muller calleja n. J Thromb Thrombolysis. 2020 Feb;49(2):228-234. doi: 10.1007/s11239-019-01970-2. J Thromb Thrombolysis. 2020. PMID: 31612355

2

Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome.

Müller-Calleja N, Köhler A, Siebald B, Canisius A, Orning C, Radsak M, Stein P, Mönnikes R, Lackner KJ. Müller-Calleja N, et al. Thromb Haemost. 2015 May;113(5):1071-83. doi: 10.1160/TH14-07-0628. Epub 2015 Jan 15. Thromb Haemost. 2015. PMID: 25589411

3

Cofactor-independent human antiphospholipid antibodies induce venous thrombosis in mice.

Manukyan D, Müller-Calleja N, Jäckel S, Luchmann K, Mönnikes R, Kiouptsi K, Reinhardt C, Jurk K, Walter U, Lackner KJ. Manukyan D, et al. J Thromb Haemost. 2016 May;14(5):1011-20. doi: 10.1111/jth.13263. Epub 2016 Mar 16. J Thromb Haemost. 2016. PMID: 26786324 Free article.

4

Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma.

Lackner KJ, Müller-Calleja N. Lackner KJ, et al. J Thromb Haemost. 2016 Jun;14(6):1117-20. doi: 10.1111/jth.13320. Epub 2016 Apr 26. J Thromb Haemost. 2016. PMID: 26998919 Free article.

5

Distribution of antiphospholipid antibodies in a large population-based German cohort.

Manukyan D, Rossmann H, Schulz A, Zeller T, Pfeiffer N, Binder H, Münzel T, Beutel ME, Müller-Calleja N, Wild PS, Lackner KJ. Manukyan D, et al. Clin Chem Lab Med. 2016 Oct 1;54(10):1663-70. doi: 10.1515/cclm-2016-0014. Clin Chem Lab Med. 2016. PMID: 27028736 Clinical Trial.

6

Antiphospholipid antibodies in a large population-based cohort: genome-wide associations and effects on monocyte gene expression.

Müller-Calleja N, Rossmann H, Müller C, Wild P, Blankenberg S, Pfeiffer N, Binder H, Beutel ME, Manukyan D, Zeller T, Lackner KJ. Müller-Calleja N, et al. Thromb Haemost. 2016 Jul 4;116(1):115-23. doi: 10.1160/TH15-12-0947. Epub 2016 Apr 21. Thromb Haemost. 2016. PMID: 27098658

7

Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma: reply.

Lackner KJ, Müller-Calleja N. Lackner KJ, et al. J Thromb Haemost. 2016 Dec;14(12):2563-2564. doi: 10.1111/jth.13523. Epub 2016 Oct 20. J Thromb Haemost. 2016. PMID: 27696707 Free article. No abstract available.

8

Pathophysiological insights into the antiphospholipid syndrome.

Lackner KJ, Manukyan D, Müller-Calleja N. Lackner KJ, et al. Hamostaseologie. 2017 Aug 8;37(3):202-207. doi: 10.5482/HAMO-16-07-0020. Epub 2016 Oct 27. Hamostaseologie. 2017. PMID: 27786332 Review.

9

Hydroxychloroquine inhibits proinflammatory signalling pathways by targeting endosomal NADPH oxidase.

Müller-Calleja N, Manukyan D, Canisius A, Strand D, Lackner KJ. Müller-Calleja N, et al. Ann Rheum Dis. 2017 May;76(5):891-897. doi: 10.1136/annrheumdis-2016-210012. Epub 2016 Nov 30. Ann Rheum Dis. 2017. PMID: 27903507

10

Mechanisms of Cellular Activation in the Antiphospholipid Syndrome.

Müller-Calleja N, Lackner KJ. Müller-Calleja N, et al. Semin Thromb Hemost. 2018 Jul;44(5):483-492. doi: 10.1055/s-0036-1597290. Epub 2017 Feb 6. Semin Thromb Hemost. 2018. PMID: 28166601 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters